Eupolio (sabin inactivated poliovirus vaccine) / Sinovac, Intravacc  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eupolio (sabin inactivated poliovirus vaccine) / Intravacc, Sinovac
NCT05431933: Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

Recruiting
3b
2000
RoW
Eupolio
LG Chem
Poliomyelitis, Vaccine Reaction
01/25
01/25
NCT03526978: An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants

Completed
3
1200
RoW
Investigational sIPV, Control IPV
Sinovac Biotech Co., Ltd
Poliomyelitis
10/17
04/18
NCT03822767: A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants

Completed
3
240
RoW
sIPV-sIPV-bOPV vaccination schedule, wIPV-wIPV-bOPV vaccination schedule
Sinovac Biotech Co., Ltd
Poliomyelitis
09/18
12/18
NCT03822754: A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants

Completed
3
240
RoW
sIPV-bOPV-bOPV vaccination schedule, wIPV-bOPV-bOPV vaccination schedule
Sinovac Biotech Co., Ltd
Poliomyelitis
09/18
12/18
NCT04386707: Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine

Completed
3
1300
RoW
Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age, Three doses of experimental sIPV of lot 2 at the schedule of 2,3,4 months of age, Three doses of experimental sIPV of lot 3 at the schedule of 2,3,4 months of age, Three doses control wIPV at the schedule of 2,3,4 months of age
Sinovac Biotech Co., Ltd
Poliomyelitis
05/20
10/20
NCT05386810: Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Completed
3
1572
RoW
Experimental vaccine, msIPV, IPV control vaccine, single-person sIPV control vaccine
Sinovac Biotech Co., Ltd
Poliomyelitis
10/22
07/23
NCT05850364: A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

Recruiting
3
1440
RoW
Sabin Strain Inactivated Poliovirus Vaccine
Sinovac Biotech Co., Ltd
Poliomyelitis, Polio
05/24
12/24

Download Options